DRAVP ID Peptide Name Source Target Organism Patent No
DRAVPa2161 Sequence 26 from Patent CN111499692B Synthetic peptide SARS-CoV-2 CN111499692B
DRAVPa2162 Sequence 27 from Patent CN111499692B Synthetic peptide SARS-CoV-2 CN111499692B
DRAVPa2163 Sequence 28 from Patent CN111499692B Synthetic peptide SARS-CoV-2 CN111499692B
DRAVPa2164 Sequence 1 from Patent US8603965B2 homo sapiens HIV US8603965B2
DRAVPa2165 Sequence 13 from Patent US9822155B2 Synthetic peptide Influenza A virus US9822155B2
DRAVPa2166 Sequence 14 from Patent US9822155B2 Synthetic peptide Influenza A virus US9822155B2
DRAVPa2167 Sequence 15 from Patent US9822155B2 Synthetic peptide Influenza A virus US9822155B2
DRAVPa2168 Sequence 16 from Patent US9822155B2 Synthetic peptide Influenza A virus US9822155B2
DRAVPa2169 Sequence 17 from Patent US9822155B2 Synthetic peptide Influenza A virus US9822155B2
DRAVPa2170 Sequence 1 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2171 Sequence 2 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2172 Sequence 3 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2173 Sequence 4 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2174 Sequence 5 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2175 Sequence 6 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2176 Sequence 7 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2177 Sequence 8 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2178 Sequence 9 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2179 Sequence 10 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
DRAVPa2180 Sequence 11 from Patent US20230256049A1 Synthetic peptide SARS-CoV-2 US20230256049A1
First 106 107 108 109 110 111 112 Last